Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Oligodendroglioma × cabazitaxel × Clear all

Sponsor

Conditions

Prostatic Neoplasms 16 Prostate Cancer Metastatic 3 Neoplasms 3 Stomach Neoplasms 2 Neoplasm Metastasis 2 Carcinoma, Transitional Cell 2 Urinary Bladder Neoplasms 1 Small Cell Lung Carcinoma 1 Recurrence 1 Metastatic Breast Cancer With Intracranial Metastases 1 Malignant Solid Tumor - Malignant Nervous System Neoplasm 1 Lymphadenopathy 1 Hormone-Resistant Prostate Cancer 1 Esophageal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Temozolomide 14 Bevacizumab 11 Erlotinib Hydrochloride 5 Radiotherapy 4 Carboplatin 4 Magnetic Resonance Spectroscopy 3 Irinotecan 3 Immunoglobulin G 3 Disulfides 3 temsirolimus 2 poly ICLC 2 palbociclib 2 etoposide phosphate 2 antineoplaston AS 2-1 2 antineoplaston A10 2 Vincristine 2 Sunitinib 2 Sirolimus 2 Everolimus 2 Dasatinib 2 2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 2 veliparib 1 varlilumab 1 vandetanib 1 trebananib 1 trametinib 1 terameprocol 1 tandutinib 1 selinexor 1 romidepsin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡